NSE filing, NSE: AVIENCE. Summary written from the filing by ALFA Finder's alert engine.
Avience Biomedicals Ltd: key numbers
- Share price
- ₹270.70
- Market cap
- ₹148.5 Cr
- Revenue (annual)
- ₹52.51 Cr
- Net profit (annual)
- ₹8.75 Cr
- P/E (TTM)
- 17.0×Sector 52.0×
- Promoter holding
- 64.59%
- FII holding
- 0.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Avience Biomedicals Ltd
All →Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.
Avience Biomedicals Other Announcement
Avience Biomedicals Limited has appointed M.A.M and Associates, GR Gupta & Associates, and V C A N & Co LLP as its statutory, secretarial, and internal auditors.
Avience Biomedicals Annual General Meeting
Avience Biomedicals Limited held its 7th AGM on September 30, 2026. Shareholders approved borrowing limits up to ₹100 Crore and the appointment of new statutory auditors.
Avience Biomedicals Annual General Meeting
Avience Biomedicals Limited has scheduled its 7th Annual General Meeting for September 30, 2026. The company also announced book closure dates for the AGM.
Avience Biomedicals Annual General Meeting
Avience Biomedicals filed notice of its 7th AGM, set for September 30, 2026, with its FY 2025-26 Annual Report. No monetary transaction is disclosed.
Avience Biomedicals Management Change
Avience Biomedicals Limited has appointed M/s. G.R. Gupta and Associates as the new Secretarial Auditor of the company for a term of 60 months.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.